Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nolla Antimicrobial Oy
OY
In liquidation
Y-tunnus 2640450-5
Erottajankatu 2, 00120
Helsinki
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2014 · 11 years old
— employees
www.nollaantimicrobial.com
Share
Finland
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Nolla Antimicrobial Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
EUR millions
2M
1M
-1M
-2M
-3M
2021: -2M
-2M
2021
2022: -1M (+50% vs 2021)
-1M
+50%
2022
2023: 1M (+200% vs 2022)
1M
+200%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
2
2
8
120
766
Staff expenses
1
1
1
−34
−199
EBITDA
−121
−121
870
−789
−1 848
Depreciation & amort.
−689
−689
−762
−502
−1 703
EBIT
−810
−810
107
−1 290
−3 551
Net financials
−56
−56
−78
−6
−289
Profit before tax
−866
−866
29
−1 296
−3 839
Tax
−0
−0
9
−0
5
Net profit
−866
−866
20
−1 296
−3 844
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
24 617
25 443
26 129
26 901
27 910
Equity
24 297
24 296
25 032
24 140
25 436
Long-term debt
0
228
0
300
578
Short-term debt
320
919
861
2 461
1 896
Total debt
320
1 147
1 097
2 761
2 474
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
98,7 %
This company
38,2 %
Market median
This company
Market median
158% above market
2021
2025
Return on equity
−3,6 %
This company
18,4 %
Market median
This company
Market median
120% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,01×
This company
0,62×
Market median
This company
Market median
98% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nolla Antimicrobial Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
